Weight Loss News and Research

Latest Weight Loss News and Research

Semaglutide linked to higher risk of vision problems, FDA data analysis shows

Researchers from the University of Bern analyzed over 300,000 FDA reports and found semaglutide use was linked to a higher reporting rate of vision impairment. The findings call for further study into the ocular risks of this widely prescribed diabetes and weight loss drug.

8 Apr 2025

Bridging the digital divide to improve heart health for all

The use of technology-based health solutions, such as fitness trackers, smartwatches and mobile health apps, has shown potential to help people improve management of their cardiovascular health.

7 Apr 2025

Reprogramming the colon could be a therapeutic strategy for short bowel syndrome

Knocking out a single gene reprograms part of the large intestine to function like the nutrient-absorbing small intestine.

3 Apr 2025

Updated screening protocols could improve early diagnosis of cystic fibrosis

All states should adopt updated screening protocols so more newborns with cystic fibrosis can be diagnosed in the first weeks of life, when interventions can have the greatest benefit, according to the Cystic Fibrosis Foundation guidelines published April 2 in the International Journal of Neonatal Screening.

3 Apr 2025

New research underscores the importance of broader health benefits in obesity care

New research to be presented at this year's European Congress on Obesity (ECO 2025, Malaga, Spain, 11-14 May) suggests that weight loss program targeting a particular % weight loss are often failing, and that other factors should be considered including improvement of obesity-related complications, enhancing quality of life and overall physical and social functioning.

3 Apr 2025

Experts develop new guidelines for the treatment of schizophrenia

New guidelines have been developed for the treatment of schizophrenia after a collaboration of international experts from 30 countries.

2 Apr 2025

Study reveals hidden cardiovascular risks in real-world low-carb diets

Researchers examined a real-world low-carbohydrate high-fat (LCHF) diet population to assess links between nutrient intake and cardiovascular risk.

2 Apr 2025

Debunking weight loss plateaus: Science says you don’t have to lose to win

New research from CSIRO, Australia’s national science agency, has busted the myth that weight loss must be a linear downward trend to be successful.

2 Apr 2025

Eating videos on social media normalize overeating and thin ideals, study finds

Researchers analyzed 180 popular eating videos on YouTube, TikTok, and Bilibili to assess their influence on body image and eating behaviors. They found frequent depictions of overeating by thin hosts, potentially normalizing unhealthy habits and reinforcing unrealistic body ideals.

1 Apr 2025

Gastric bypass proven most effective for severe obesity in landmark study

Gastric bypass is the most clinically and cost effective form of interventional surgery for people living with severe obesity, reveals landmark research funded and supported by the National Institute for Health and Care Research (NIHR).

1 Apr 2025

UVA Health experts highlight a growing array of treatment options for type 2 diabetes

Nearly 40% of patients diagnosed with type 2 diabetes imperil their health by stopping their medication within the first year, UVA Health diabetes experts note in a new paper highlighting a growing array of treatment options.

1 Apr 2025

Do lifetime body weight patterns affect kidney cancer risk?

Excess weight in mid-life is a known risk factor for kidney cancer, but new research indicates that weight patterns throughout life may also affect an individual’s likelihood of developing this malignancy.

1 Apr 2025

Tirzepatide improves kidney, cardiovascular function in patients with obesity and HFpEF

The drug tirzepatide improved kidney function and cardiovascular outcomes among patients with obesity and heart failure with preserved ejection fraction (HFpEF) compared with placebo at one year, according to featured clinical research presented at the American College of Cardiology's Annual Scientific Session (ACC.25) and simultaneously published in JACC.

31 Mar 2025

Semaglutide improves maximal walking distance in people with symptomatic PAD and Type 2 diabetes

Semaglutide, a glucagon-like peptide 1 (GLP-1) agonist, significantly improved maximal walking distance in people with symptomatic peripheral artery disease (PAD) and Type 2 diabetes in the first-of-its kind trial to evaluate the use of a GLP-1 agonist to manage PAD.

29 Mar 2025